The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events
NCT ID: NCT01249924
Last Updated: 2013-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2009-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP Group
CPAP Treatment
auto-titrated CPAP
Patients will be treated with auto-CPAP preoperatively for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Control Group
Routine care
auto-titrated CPAP
Patients will be treated with auto-CPAP preoperatively for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Control
Patients in this group will receive routine care, undergo sleep study on the third postoperative night and be monitored by a pulse oximeter for oxygen saturation level for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
auto-titrated CPAP
Patients will be treated with auto-CPAP preoperatively for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Control
Patients in this group will receive routine care, undergo sleep study on the third postoperative night and be monitored by a pulse oximeter for oxygen saturation level for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who are scheduled for inpatient surgery that required a minimum of three nights of hospital stay
* Age: \>18 and \<80 years old.
* Identified as high risk of having OSA or diagnosed with OSA without using CPAP.
Exclusion Criteria
* Unwilling or unable to give informed consent.
* Currently undergoing treatment for sleep apnea including CPAP.
* Requiring prolonged postoperative ventilation.
* New York Heart Association functional class III and IV.
* Having valvular heart disease, dilated cardiomyopathy, implanted cardiac pacemaker, or unstable angina.
* Having myocardial infarction or cardiac surgery within 3 months.
* Having chronic obstructive pulmonary disease, or asthma.
* Having a presence of tracheostomy, facial, neck, or chest wall abnormalities.
* Having abdominal aortic aneurysm surgery, chemotherapy, or immunosuppressive therapy within 3 months.
* Visiting preoperative clinic less than 3 days before scheduled surgery date.
* On nasogastric tube postoperatively.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Frances Chung
Anesthesiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frances Chung, FRCPC
Role: PRINCIPAL_INVESTIGATOR
University Health Network, Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Western Hospital, Department of Aneshtesia
Toronto, Ontario, Canada
Mount Sinai Hospital, Department of Anesthesia
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000
Identifier Type: -
Identifier Source: org_study_id